---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291314552.md"
description: "HeartBeam shares are trading higher after the company announced completion of patient enrollment in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection."
datetime: "2026-06-30T15:31:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291314552.md)
  - [en](https://longbridge.com/en/news/291314552.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291314552.md)
generator: "portal-rs"
---

# 

HeartBeam shares are trading higher after the company announced completion of patient enrollment in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection.

### Related Stocks

- [BEAT.US](https://longbridge.com/en/quote/BEAT.US.md)
- [BEATW.US](https://longbridge.com/en/quote/BEATW.US.md)

## Related News & Research

- [HeartBeam posts Q2 presentation outlining heart attack detection progress and initial commercial launch traction](https://longbridge.com/en/news/295840063.md)
- [HeartBeam Buy Rating Reiterated as Clinical and Commercial Momentum Strengthens; $2 Price Target Maintained](https://longbridge.com/en/news/296257396.md)
- [Quiron study REACT finds 57.1% of adults without known heart disease have silent atherosclerosis](https://longbridge.com/en/news/297484267.md)
- [Pharvaris reports Phase 2 CHAPTER-1 extension data showing long-term safety, attack-rate drop for deucrictibant in HAE](https://longbridge.com/en/news/297900979.md)
- [NewAmsterdam Pharma (NAMS) Heads To ESC 2026 With Phase 3 Data, Is It Still 76% Below Fair Value?](https://longbridge.com/en/news/298060195.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**